164 related articles for article (PubMed ID: 36335129)
1. LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia.
Xie Y; Lin H; Wei W; Kong Y; Fang Q; Chen E; Liu J; Li M
Sci Rep; 2022 Nov; 12(1):18757. PubMed ID: 36335129
[TBL] [Abstract][Full Text] [Related]
2. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression.
Zhou X; Chang Y; Zhu L; Shen C; Qian J; Chang R
Bioengineered; 2021 Dec; 12(2):10849-10861. PubMed ID: 34634995
[TBL] [Abstract][Full Text] [Related]
3. LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1.
Zhang Q; Wei J; Li N; Liu B
Neurochem Res; 2022 Aug; 47(8):2278-2293. PubMed ID: 35606572
[TBL] [Abstract][Full Text] [Related]
4. LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.
Liu X; Chen J; Zhang S; Liu X; Long X; Lan J; Zhou M; Zheng L; Zhou J
EMBO Rep; 2022 Sep; 23(9):e54128. PubMed ID: 35876654
[TBL] [Abstract][Full Text] [Related]
5. m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.
Zheng WH; Long ZQ; Zheng ZQ; Zhang LL; Liang YL; Li ZX; Lv JW; Kou J; Hong XH; He SW; Xu R; Zhou GQ; Liu N; Ma J; Sun Y; Lin L; Wei D
J Biol Chem; 2023 Jul; 299(7):104873. PubMed ID: 37257820
[TBL] [Abstract][Full Text] [Related]
6. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC.
Yan Y; Wang Z; Qin B
Biochem Biophys Res Commun; 2019 Feb; 509(2):441-447. PubMed ID: 30594388
[TBL] [Abstract][Full Text] [Related]
7. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway.
Chen Q; Shen H; Zhu X; Liu Y; Yang H; Chen H; Xiong S; Chi H; Xu W
Cancer Sci; 2020 Sep; 111(9):3279-3291. PubMed ID: 32619088
[TBL] [Abstract][Full Text] [Related]
8. LINC00839 Promotes the Progression of Gastric Cancer by Sponging miR-1236-3p.
An JX; Ma ZS; Yu WJ; Xie BJ; Zhu FS; Zhou YX; Cao FL
Bull Exp Biol Med; 2022 May; 173(1):81-86. PubMed ID: 35622250
[TBL] [Abstract][Full Text] [Related]
9. [Effects of LINC00839 targeting miR-3666 on proliferation, migration and invasion of hepatocellular carcinoma cells].
Meng B; Han F; Gao B; Zhuang H; Zhang XZ; Wang YJ; Zhang M
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1148-1155. PubMed ID: 34794216
[No Abstract] [Full Text] [Related]
10. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
11. LINC00839/miR-519d-3p/JMJD6 axis modulated cell viability, apoptosis, migration and invasiveness of lung cancer cells.
Yu X; Jiang Y; Hu X; Ge X
Folia Histochem Cytobiol; 2021; 59(4):271-281. PubMed ID: 34734406
[TBL] [Abstract][Full Text] [Related]
12. EGR1/
Wang Z; Wei B; Ma S
Cancer Biol Ther; 2023 Dec; 24(1):2270106. PubMed ID: 37862152
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
15. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p.
Zhou Y; Huang Y; Hu K; Zhang Z; Yang J; Wang Z
Cell Death Dis; 2020 Mar; 11(3):176. PubMed ID: 32152275
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA LINC00839 Promotes the Malignant Progression of Osteosarcoma by Competitively Binding to MicroRNA-454-3p and Consequently Increasing c-Met Expression.
Zhang Y; Guo H; Ma L; Chen X; Chen G
Cancer Manag Res; 2020; 12():8975-8987. PubMed ID: 33061593
[TBL] [Abstract][Full Text] [Related]
17. LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis.
Shao HJ; Li Q; Shi T; Zhang GZ; Shao F
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3749-3759. PubMed ID: 31115001
[TBL] [Abstract][Full Text] [Related]
18. HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription.
Yan H; He N; He S
Biochem Biophys Res Commun; 2022 Jun; 608():170-176. PubMed ID: 35427894
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling.
Wei H; Xu Z; Chen L; Wei Q; Huang Z; Liu G; Li W; Wang J; Tang Q; Pu J
Cell Death Dis; 2022 Feb; 13(2):102. PubMed ID: 35110549
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
